+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Nicotinamide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 185 Pages
  • April 2025
  • Region: Global
  • TechSci Research
  • ID: 6075804
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Nicotinamide Market was valued at USD 2024 in 0.62 Billion, and is expected to reach USD 1.09 Billion by 2030, rising at a CAGR of 6.61%. Nicotinamide, also known as niacinamide, is a water-soluble form of vitamin B3 that plays a vital role in metabolic function and cellular repair. Its wide applicability across pharmaceutical, dietary, and cosmetic products positions it as a critical ingredient in various consumer health and wellness segments. Growing awareness of its benefits in skin care, inflammation control, and metabolic health is fueling its adoption across both therapeutic and lifestyle-related applications. Increasing demand from emerging markets, where health and personal care spending is on the rise, further contributes to the upward trajectory of the nicotinamide market. However, challenges such as raw material dependency and regulatory scrutiny may impact long-term growth if not effectively addressed.

Key Market Drivers

Growth in Pharmaceutical Industry

The growing demand from the global pharmaceutical industry is a primary driver propelling the nicotinamide market. With the global healthcare sector generating more than USD 4 trillion annually - USD 850 billion from pharmaceuticals and biotechnology alone - nicotinamide's role in therapeutic formulations is expanding rapidly. It is widely used to treat niacin deficiency disorders, support dermatological therapies, and enhance metabolic health. Recent developments, such as Zhejiang University’s co-crystallization of Ticagrelor with Nicotinamide to enhance drug solubility, underscore the compound’s value in improving pharmaceutical formulations. As global pharmaceutical innovation continues to focus on solubility, efficacy, and patient outcomes, the incorporation of nicotinamide is expected to increase further across prescription and over-the-counter product categories.

Key Market Challenges

Fluctuating Raw Material Prices

Volatility in raw material prices is a key challenge for the nicotinamide market. The compound is primarily synthesized from nicotine, which is extracted from tobacco - a crop subject to variable supply conditions and geopolitical influences. Fluctuations in raw material availability or pricing can disrupt production stability and increase operational costs. These pressures are particularly impactful in regions where raw material sourcing is heavily reliant on imports. Rising sustainability standards and the need for consistent, cost-effective manufacturing practices place additional strain on producers, especially those operating in price-sensitive markets. As a result, manufacturers must continuously monitor and adapt to raw material market dynamics to ensure competitiveness.

Key Market Trends

Growth in the Dietary Supplement Sector

The dietary supplement sector is emerging as a major growth avenue for nicotinamide. With increasing consumer interest in preventive healthcare, wellness, and anti-aging, demand for nicotinamide-based supplements is on the rise. Notably, derivatives like Nicotinamide Riboside (NR), which boosts NAD+ levels in cells, are gaining traction for their potential anti-aging and metabolic benefits. This interest extends beyond general health, with pharmaceutical research exploring NR’s applications in areas such as neurological health and energy metabolism. As consumers seek functional ingredients with clinically proven benefits, nicotinamide’s presence in the supplement market continues to strengthen, supported by a growing body of scientific evidence and shifting consumer health priorities.

Key Market Players

  • Nebula Health Care
  • Suchem Laboratory
  • Western Drugs Limited
  • Roopa Industries Limited
  • S.V. Labs Pvt. Ltd.
  • Veer Chemie & Aromatics Pvt Ltd.
  • Optimus Drugs Pvt. Ltd
  • NIGAM FINECHEM PVT. LTD
  • Ishita Drugs & Industries Ltd
  • Anhui Redpont Biotechnology Co., Ltd

Report Scope:

In this report, the Global Nicotinamide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nicotinamide Market, By Sales Channel:

  • Direct
  • Indirect

Nicotinamide Market, By End Use:

  • Pharmaceuticals
  • Cosmetics & Personal Care
  • Food & Beverages
  • Animal Feed
  • Chemicals

Nicotinamide Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nicotinamide Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Nicotinamide Market
5. Global Nicotinamide Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Sales Channel (Direct, Indirect)
5.2.2. By End Use (Pharmaceuticals, Cosmetics & Personal Care, Food & Beverages, Animal Feed, Chemicals)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Nicotinamide Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Sales Channel
6.2.2. By End Use
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Nicotinamide Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Sales Channel
6.3.1.2.2. By End Use
6.3.2. Mexico Nicotinamide Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Sales Channel
6.3.2.2.2. By End Use
6.3.3. Canada Nicotinamide Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Sales Channel
6.3.3.2.2. By End Use
7. Europe Nicotinamide Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Sales Channel
7.2.2. By End Use
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Nicotinamide Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Sales Channel
7.3.1.2.2. By End Use
7.3.2. Germany Nicotinamide Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Sales Channel
7.3.2.2.2. By End Use
7.3.3. United Kingdom Nicotinamide Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Sales Channel
7.3.3.2.2. By End Use
7.3.4. Italy Nicotinamide Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Sales Channel
7.3.4.2.2. By End Use
7.3.5. Spain Nicotinamide Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Sales Channel
7.3.5.2.2. By End Use
8. Asia Pacific Nicotinamide Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Sales Channel
8.2.2. By End Use
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Nicotinamide Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Sales Channel
8.3.1.2.2. By End Use
8.3.2. India Nicotinamide Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Sales Channel
8.3.2.2.2. By End Use
8.3.3. South Korea Nicotinamide Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Sales Channel
8.3.3.2.2. By End Use
8.3.4. Japan Nicotinamide Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Sales Channel
8.3.4.2.2. By End Use
8.3.5. Australia Nicotinamide Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Sales Channel
8.3.5.2.2. By End Use
9. South America Nicotinamide Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Sales Channel
9.2.2. By End Use
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Nicotinamide Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Sales Channel
9.3.1.2.2. By End Use
9.3.2. Argentina Nicotinamide Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Sales Channel
9.3.2.2.2. By End Use
9.3.3. Colombia Nicotinamide Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Sales Channel
9.3.3.2.2. By End Use
10. Middle East and Africa Nicotinamide Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Sales Channel
10.2.2. By End Use
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Nicotinamide Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Sales Channel
10.3.1.2.2. By End Use
10.3.2. Saudi Arabia Nicotinamide Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Sales Channel
10.3.2.2.2. By End Use
10.3.3. UAE Nicotinamide Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Sales Channel
10.3.3.2.2. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Nicotinamide Market: SWOT Analysis
14. Porters Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Nebula Health Care
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Suchem Laboratory
15.3. Western Drugs Limited
15.4. Roopa industries limited
15.5. S.V. Labs Pvt. Ltd.
15.6. Veer Chemie & Aromatics pvt ltd.
15.7. Optimus Drugs Pvt. Ltd
15.8. NIGAM FINECHEM PVT. LTD
15.9. Ishita Drugs & Industries Ltd
15.10. Anhui Redpont Biotechnology Co., Ltd
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

  • Nebula Health Care
  • Suchem Laboratory
  • Western Drugs Limited
  • Roopa industries limited
  • S.V. Labs Pvt. Ltd.
  • Veer Chemie & Aromatics pvt ltd.
  • Optimus Drugs Pvt. Ltd
  • NIGAM FINECHEM PVT. LTD
  • Ishita Drugs & Industries Ltd
  • Anhui Redpont Biotechnology Co., Ltd